🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10178+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10178 recruiting trials

Phase 1RecruitingNCT07261631

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

🏥 Novartis Pharmaceuticals📍 5 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07209462

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

🏥 Mirum Pharmaceuticals, Inc.📍 15 sites📅 Started Nov 2025View details ↗
RecruitingNCT07090460

Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

🏥 Centre Hospitalier de la côte Basque📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07389629

Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

🏥 Sun Yat-sen University📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06986174

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

👨‍⚕️ Shayna Sarosiek, MD, Dana-Farber Cancer Institute📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT07532824

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

🏥 Institute of Hematology and Blood Transfusion, Czech Republic📍 2 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07328425

Clinical Study in Patients With DSRCT

👨‍⚕️ Silvia Syecchiotti, MD, Findazione IRCCS Istituto Nazionale Tumori Milano📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT06681818

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

👨‍⚕️ Cherif Boutros, MD, Englewood Hospital📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07158229

Long-term Impact of NMDAR Encephalitis, Level 3

👨‍⚕️ Jérôme HONNORAT, Pr📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07232680

Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy

👨‍⚕️ Rodney Cheng En Hsieh, MD, PhD, Chang Gung Memorial Hospital📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07213648

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

🏥 University of Virginia📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07328854

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

👨‍⚕️ Ming-Yuan Chen, MD,PhD, Sun Yat-sen University📍 15 sites📅 Started Nov 2025View details ↗
Enrolling by InvitationNCT07055503

Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

👨‍⚕️ Antonis Kattamis, Professor, National and Kapodistrian University of Athens📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07272798

Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension

👨‍⚕️ Mohammad B Izzat, FRCS(CTh), Damascus University School of Medicine📍 1 site📅 Started Nov 2025View details ↗
RecruitingNCT07249515

Scapula and Upper Extremity Performance in Scoliosis

🏥 Istinye University📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT07300696

Functional MRI for Monitoring Progression and Assessing Trends in ILD

🏥 University Hospital Heidelberg📍 2 sites📅 Started Nov 2025View details ↗
EARLY_Phase 1RecruitingNCT06693284

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]

👨‍⚕️ Robert Galvin, MD, University of Minnesota📍 1 site📅 Started Nov 2025View details ↗
Phase 3RecruitingNCT07087054

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

🏥 Crinetics Pharmaceuticals Inc.📍 43 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT07161037

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

🏥 Vertex Pharmaceuticals Incorporated📍 35 sites📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07076550

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

🏥 Alpha-9 Oncology USA Inc.📍 4 sites📅 Started Nov 2025View details ↗
← PreviousPage 43 of 509Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →